Influence of different adrenoceptor agonists and antagonists on physostigmine-induced yawning in rats

被引:9
作者
Zarrindast, MR
Fazli-Tabai, S
Semnanian, S
Fathollahi, Y
机构
[1] Univ Tehran, Sch Med, Dept Pharmacol, Tehran, Iran
[2] Azad Univ Kazeron, Dept Physiol, Kazeron, Iran
[3] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
[4] Tarbiat Modares Univ, Sch Med Sci, Dept Physiol, Tehran, Iran
关键词
adrenergic agents; physostigmine; yawning; rats;
D O I
10.1016/S0091-3057(98)00143-9
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
In the present study, effects of adrenoceptor agonists and antagonists on physostigmine-induced yawning was investigated. Intraperitoneal (IP) injection of different doses of physostigmine (0.03, 0.05, 0.1, and 0.2 mg/kg) induced yawning in rats. The maximum response was obtained by 0.2 mg/kg of the drug. The alpha(1)-adrenoceptor agonist, phenylephrine, and the alpha(2)-adrenoceptor agonist, clonidine, decreased yawning induced by physostigmine. Prazosin and higher doses of phenoxybenzamine reduced the inhibitory effect of phenylephrine. Higher doses of yohimbine also reduced the clonidine response. The adrenoceptor antagonists, prazosin, phenoxybenzamine, and propranolol, did not significantly alter the physostigmine response. However, yohimbine, or lower doses of prazosin, decreased the physostigmine response. It may be concluded that alpha(1)- and alpha(2)-adrenoceptor stimulation decreases the physostigmine-induced yawning behavior in rats. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 21 条
[11]   INTRACEREBROVENTRICULAR INJECTION OF HEMICHOLINIUM-3 PREVENTS THE ACTH-INDUCED, BUT NOT THE PHYSOSTIGMINE-INDUCED, REVERSAL OF HEMORRHAGIC-SHOCK IN RATS [J].
GUARINI, S ;
TAGLIAVINI, S ;
BAZZANI, C ;
FERRANTE, F ;
BERTOLINI, A .
PHARMACOLOGY, 1990, 40 (02) :85-89
[12]   POST SYNAPTIC 5-HT1A RECEPTOR INVOLVEMENT IN YAWNING AND PENILE ERECTIONS INDUCED BY APOMORPHINE, PHYSOSTIGMINE AND MCPP IN RATS [J].
PROTAIS, P ;
WINDSOR, M ;
MOCAER, E ;
COMOY, E .
PSYCHOPHARMACOLOGY, 1995, 120 (04) :376-383
[13]   5-HT(1A) RECEPTOR AGONISTS PREVENT IN RATS THE YAWNING AND PENILE ERECTIONS INDUCED BY DIRECT DOPAMINE AGONISTS [J].
SIMON, P ;
GUARDIOLA, B ;
BIZOTESPIARD, J ;
SCHIAVI, P ;
COSTENTIN, J .
PSYCHOPHARMACOLOGY, 1992, 108 (1-2) :47-50
[14]   The effects of melanocortin agonists leptin-induced fever in and antagonists on rats [J].
Turek, VF ;
Olster, DH ;
Gililland, KR ;
Sheehy, M ;
Ettenberg, A ;
Carlisle, HJ .
JOURNAL OF THERMAL BIOLOGY, 2004, 29 (7-8) :423-430
[15]   Combination therapy with β3-adrenoceptor agonists and muscarinic acetylcholine receptor antagonists: Efficacy in rats with bladder overactivity [J].
Furuta, Akira ;
Suzuki, Yasuyuki ;
Kimura, Shoji ;
Koike, Yusuke ;
Egawa, Shin ;
Yoshimura, Naoki .
INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (05) :425-430
[16]   Effect of alpha-adrenoceptor agonists and antagonists on imipramine-induced antinociception in the rat formalin test [J].
Zarrindast, MR ;
Sahebgharani, M .
PHARMACOLOGY, 2002, 64 (04) :201-207
[17]   Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors [J].
Depoortere, Ronan ;
Bardin, Laurent ;
Rodrigues, Michael ;
Abrial, Erika ;
Aliaga, Monique ;
Newman-Tancredi, Adrian .
BEHAVIOURAL PHARMACOLOGY, 2009, 20 (04) :303-311
[18]   PENILE ERECTION AND YAWNING INDUCED BY 5-HT1C RECEPTOR AGONISTS IN MALE-RATS - RELATIONSHIP WITH DOPAMINERGIC AND OXYTOCINERGIC TRANSMISSION [J].
STANCAMPIANO, R ;
MELIS, MR ;
ARGIOLAS, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 261 (1-2) :149-155
[19]   EFFECT OF EXCITATORY AMINO-ACID RECEPTOR ANTAGONISTS ON APOMORPHINE-INDUCED, OXYTOCIN-INDUCED AND ACTH-INDUCED PENILE ERECTION AND YAWNING IN MALE-RATS [J].
MELIS, MR ;
STANCAMPIANO, R ;
ARGIOLAS, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 220 (01) :43-48
[20]   Effects of adenosine receptor agonists and antagonists in amphetamine-induced conditioned place preference test in rats. [J].
Poleszak, E ;
Malec, D .
POLISH JOURNAL OF PHARMACOLOGY, 2003, 55 (03) :319-326